Keller and Heckman offers global food and drug services to its clients. Our comprehensive and extensive food and drug practice is one of the largest in the world. We promote, protect, and defend products made by the spectrum of industries regulated by the U.S. Food and Drug Administration (FDA), the European Commission and Member States authorities in the European Union (EU) and similar authorities throughout the world. The products we help get to market include foods, pharmaceuticals, medical devices, veterinary products, dietary supplements, and cosmetics. In addition, we have a very comprehensive practice in the regulation of packaging materials for food, drugs, and cosmetics and other food-contact articles. We represent clients in addressing all issues relating to these products, including the suitability of their composition, inspection of manufacturing facilities, labeling and advertising, recall procedures, quality assurance programs, and appropriate responses to consumer complaints and tampering incidents. We also vigorously defend our clients when threatened by unwarranted action by competitors or regulatory authorities. We also have substantial experience conducting "due diligence" audits of marketed products, labeling, advertising claims, and manufacturing operations, both for the clients' internal control purposes and as part of product line or corporate acquisitions.
More Legal and Business Bylines From Food and Drug Law at Keller and Heckman
- FDA Announces New Steps to Protect Youth From Tobacco Harms; National Youth Tobacco Survey Results Released - (Posted On Friday, November 16, 2018)
- CDC Issues Update on Multistate Salmonella Outbreak Linked to Raw Turkey - (Posted On Thursday, November 15, 2018)
- Post-Election, Oregon and Washington’s Proposed Soda Tax Bans Reach Different Results - (Posted On Wednesday, November 14, 2018)
- New Report Reveals Sources of Foodborne Illnesses - (Posted On Tuesday, November 13, 2018)
- Stakeholder Comments Reflect Discontent with FDA’s Draft Guidance for Quantitative Labeling of Supplements Containing Live Microbials - (Posted On Monday, November 12, 2018)
- FDA Announces Meeting to Discuss Eliminating Youth E-Cigarette Use - (Posted On Friday, November 09, 2018)
- FDA Releases Initial Findings on Food Safety in Restaurants - (Posted On Thursday, November 08, 2018)
- Days after Joint FDA/USDA Meeting on Cell Culture Technology, GFI and Others Request Preliminary Injunction on Missouri Law Banning Use of “Meat” on Plant-Based Product Labels - (Posted On Wednesday, November 07, 2018)
- FDA Publishes Q&A Guidance on Mandatory Food Recalls - (Posted On Tuesday, November 06, 2018)
- FDA Finalizes Compliance Dates for Nutrition Facts Label and Serving Size Rules and Issues New Final and Draft Guidance Documents - (Posted On Monday, November 05, 2018)
Keller and Heckman’s Food and Drug Law Practice Group is a Go-To Thought Leader for 2021 for its coverage of Food Labeling Class Action Lawsuits and Regulatory news. The group regularly provides interesting, comprehensive news on topics ranging from class-action lawsuits involving Snack Foods lacking real Wasabi and Canned Green Beans inaccurately claiming to be preservative-free, to proposed federal legislation regulating CBD in food products. NLR readers appreciate the group’s efforts to break down lawsuits and pending legislation impacting the nation's food supply.
The National Law Review Recognizes Keller and Heckman’s Food and Drug Law Practice Group as Go-To Thought Leaders for the firm’s contributions on FDA Regulations and guidelines. Keller and Heckman’s expansive FDA coverage included: proposed rules expanding food traceability and record-keeping requirements, new guidance for animal food additives, a final rule concerning gluten-free food labeling, and approval of a new peanut allergy drug. Addressing the COVID-19 crisis, Keller & Heckman provided news about warnings required by the FDA for Purell and other actions about hand sanitizer and additional Coronavirus prevention and cure claims, the FDA’s and OSHA’s employee health and food safety checklist(s) and COVID-19 best practices for retail and restaurants and COVID-19 Guidance to U.S. food exporters. The firm’s most frequent FDA / Food and Drug Law attorney contributors to the NLR include Azim Chowdhury, Sheila A. Millar, Evangelia Pelonis, Natalie Rainer and LieAnn Van-Tull.